Clark Capital Management Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$77M Buy
640,272
+622,454
+3,493% +$71.9M 0.48% 58
2025
Q4
$1.88M Sell
17,818
-905
-5% -$85K 0.01% 270
2025
Q3
$1.57M Buy
18,723
+554
+3% +$45.6K 0.01% 271
2025
Q2
$1.44M Sell
18,169
-3,875
-18% -$308K 0.01% 280
2025
Q1
$1.98M Sell
22,044
-359,592
-94% -$33.6M 0.01% 266
2024
Q4
$38M Sell
381,636
-267,827
-41% -$27.6M 0.27% 119
2024
Q3
$73.8M Sell
649,463
-475,240
-42% -$56.5M 0.51% 57
2024
Q2
$139M Buy
1,124,703
+61,458
+6% +$7.92M 1.02% 17
2024
Q1
$140M Buy
1,063,245
+356,277
+50% +$43.9M 1.05% 14
2023
Q4
$77.1M Buy
706,968
+253,428
+56% +$26.3M 0.63% 36
2023
Q3
$46.7M Sell
453,540
-453,604
-50% -$48.9M 0.47% 61
2023
Q2
$105M Buy
907,144
+24,639
+3% +$2.8M 0.94% 15
2023
Q1
$93.9M Sell
882,505
-143,601
-14% -$15.5M 1.05% 12
2022
Q4
$114M Buy
1,026,106
+49,059
+5% +$5.01M 1.05% 9
2022
Q3
$84.1M Sell
977,047
-88,806
-8% -$7.93M 1.1% 11
2022
Q2
$97.2M Buy
1,065,853
+679,175
+176% +$60.2M 1.28% 10
2022
Q1
$31.7M Buy
386,678
+9,253
+2% +$730K 0.35% 86
2021
Q4
$28.9M Buy
377,425
+24,537
+7% +$1.95M 0.35% 118
2021
Q3
$26.5M Sell
352,888
-244,655
-41% -$18.6M 0.36% 117
2021
Q2
$46.5M Buy
597,543
+89,140
+18% +$6.63M 0.65% 36
2021
Q1
$37.4M Buy
508,403
+253,918
+100% +$18.7M 0.57% 47
2020
Q4
$19.9M Sell
254,485
-11,809
-4% -$903K 0.33% 133
2020
Q3
$21.1M Buy
266,294
+124
+0% +$9.71K 0.4% 107
2020
Q2
$19.6M Sell
266,170
-348,245
-57% -$26.2M 0.37% 108
2020
Q1
$45.1M Sell
614,415
-391,776
-39% -$30.8M 1.15% 21
2019
Q4
$87.3M Buy
1,006,191
+98,771
+11% +$8.11M 1.83% 8
2019
Q3
$72.9M Buy
907,420
+901,130
+14,326% +$72.2M 1.65% 8
2019
Q2
$503K Buy
6,290
+226
+4% +$17.3K 0.01% 242
2019
Q1
$481K Buy
6,064
+680
+13% +$50.9K 0.01% 246
2018
Q4
$393K Buy
5,384
+437
+9% +$30.8K 0.01% 252
2018
Q3
$335K Sell
4,947
-181
-4% -$11.5K 0.01% 249
2018
Q2
$297K Sell
5,128
-424
-8% -$23.9K 0.01% 246
2018
Q1
$289K Sell
5,552
-7,343
-57% -$397K 0.01% 254
2017
Q4
$692K Sell
12,895
-496,761
-97% -$27.5M 0.02% 220
2017
Q3
$31.1M Buy
509,656
+44,513
+10% +$2.7M 1.05% 23
2017
Q2
$28.4M Buy
465,143
+134,457
+41% +$8.18M 1.11% 26
2017
Q1
$20M Buy
330,686
+317,219
+2,356% +$19.2M 0.89% 32
2016
Q4
$756K Hold
13,467
0.04% 217
2016
Q3
$802K Sell
13,467
-47
-0.3% -$2.75K 0.05% 223
2016
Q2
$743K Sell
13,514
-2,453
-15% -$131K 0.05% 203
2016
Q1
$806K Buy
15,967
+1,441
+10% +$70.6K 0.06% 184
2015
Q4
$732K Sell
14,526
-4,572
-24% -$231K 0.06% 179
2015
Q3
$900K Sell
19,098
-163,365
-90% -$8.68M 0.08% 175
2015
Q2
$9.91M Buy
182,463
+96,192
+111% +$5.39M 0.91% 31
2015
Q1
$4.73M Sell
86,271
-84,537
-49% -$4.79M 0.43% 71
2014
Q4
$9.26M Sell
170,808
-16,893
-9% -$941K 0.85% 35
2014
Q3
$10.6M Buy
187,701
+49,404
+36% +$2.77M 0.92% 24
2014
Q2
$7.63M Sell
138,297
-37,563
-21% -$2.05M 0.64% 47
2014
Q1
$9.53M Buy
175,860
+39,603
+29% +$2.05M 0.82% 27
2013
Q4
$6.51M Sell
136,257
-9,239
-6% -$422K 0.54% 47
2013
Q3
$6.61M Buy
145,496
+8,384
+6% +$383K 0.52% 45
2013
Q2
$6.08M Buy
+137,112
New +$6.12M 0.56% 43

Other funds holding MRK

Clark Capital Management Group's MRK Position: Q1 2026 in Review

Clark Capital Management Group increased its Merck (MRK) stake by 3,493% in Q1 2026, buying an estimated $71.9M and bringing the position to 640,272 shares worth $77M. The position accounts for 0.48% of the portfolio, ranked #58.

Clark Capital Management Group first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $140M in Q1 2024. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Clark Capital Management Group held 640,272 shares of Merck worth $77M as of Q1 2026.
  • Clark Capital Management Group bought 622,454 Merck shares in Q1 2026, an estimated $71.9M.
  • Merck made up 0.48% of Clark Capital Management Group's portfolio in Q1 2026, its #58 holding.
  • Clark Capital Management Group first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Clark Capital Management Group's Merck position peaked at $140M in Q1 2024.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Clark Capital Management Group's 13F filing for Q1 2026, filed 15 May 2026.